We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
0 hedge funds and large institutions have $760 invested in Regulus Therapeutics in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
82.36% less ownership
Funds ownership: 82.36% → 0% (-82%)
100% less funds holding
Funds holding: 75 → 0 (-75)
100% less capital invested
Capital invested by funds: $107M → $760 (-$107M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 75
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $224K
Holders
–
Holders Change
-75
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
75
Calls
–
Puts
$224K
Net Calls
-$224K
Net Calls Change
-$495K
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$39.2M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$11.3M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$8.11M |
| 4 |
BlackRock
New York
|
-$7.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.92M |